Detected ·
Click Therapeutics, Inc.
——
Click Therapeutics, Inc. announced a Series D investment and a new strategic agreement with Boehringer Ingelheim to advance commercialization of CT-155, a prescription digital therapeutic for schizophrenia.
- Website
- www.clicktherapeutics.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-09 18:07:37 UTC
- Signal ID
- a8f09c4e-0dbe-4a1d-8c77-49e192f7e65f
As the API returns it
{
"id": "a8f09c4e-0dbe-4a1d-8c77-49e192f7e65f",
"created_at": "2026-04-09T18:07:37.041299Z",
"company_name": "Click Therapeutics, Inc.",
"company_website_url": "www.clicktherapeutics.com",
"company_linkedin_url": "https://www.linkedin.com/company/click-therapeutics-inc-",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Click Therapeutics, Inc. announced a Series D investment and a new strategic agreement with Boehringer Ingelheim to advance commercialization of CT-155, a prescription digital therapeutic for schizophrenia.*"
}